Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (427K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Bardeesy, N.
Right arrow Articles by Pelletier, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bardeesy, N.
Right arrow Articles by Pelletier, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 7 1784-1792, Copyright © 1998 by Oxford University Press


ARTICLES

Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product

N Bardeesy and J Pelletier
Department of Biochemistry, McGill University, 3655 Drummond Street, Montreal, Quebec H3G 1Y6, Canada.

The Wilms' tumour suppressor gene (wt1) is mutated in a subset of patients with Wilms' tumour and has a critical role in urogenital development. wt1 encodes a zinc finger transcription factor which regulates expression of several genes involved in cellular proliferation and differentiation. Although a number of studies have characterized the DNA binding properties of the WT1 protein, recent evidence has suggested that WT1 may also have a role in RNA metabolism. We have used an RNA selection method to identify WT1 binding ligands from a random RNA pool. Three groups of RNA ligands specifically recognized by WT1 were identified. Mutational analysis pinpointed ribonucleotide sequences critical for binding. Analysis of truncated WT1 proteins demonstrated that three of four zinc fingers were necessary for RNA-protein interaction. The naturally occurring WT1 isoforms with insertion of lysine, threonine and serine between zinc fingers three and four were unable to bind the selected RNAs. The selected RNA ligands competed with the cognate WT1 DNA binding site for complex formation with WT1. Our findings suggest potential cellular RNA target sequences for WT1 and provide tools for studying the structural and functional properties of this tumour suppressor protein.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Osada, C. Y. Woo, M. McKinney, X. Y. Yang, G. Lei, H. G. LaBreche, Z. C. Hartman, D. Niedzwiecki, N. Chao, A. Amalfitano, et al.
Induction of Wilms' Tumor Protein (WT1)-Specific Antitumor Immunity Using a Truncated WT1-Expressing Adenovirus Vaccine
Clin. Cancer Res., April 15, 2009; 15(8): 2789 - 2796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. A. Morrison, R. L. Viney, M. A. Saleem, and M. R. Ladomery
New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F12 - F17.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. A. Schumacher, S. Jeruschke, F. Eitner, J. U. Becker, G. Pitschke, Y. Ince, J. H. Miner, I. Leuschner, R. Engers, A. S. Everding, et al.
Impaired Glomerular Maturation and Lack of VEGF165b in Denys-Drash Syndrome
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 719 - 729.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Y. Bor, J. Swartz, A. Morrison, D. Rekosh, M. Ladomery, and M.-L. Hammarskjold
The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron
Genes & Dev., June 15, 2006; 20(12): 1597 - 1608.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. T. Discenza and J. Pelletier
Insights into the physiological role of WT1 from studies of genetically modified mice
Physiol Genomics, February 13, 2004; 16(3): 287 - 300.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Ladomery, J. Sommerville, S. Woolner, J. Slight, and N. Hastie
Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one
J. Cell Sci., April 15, 2003; 116(8): 1539 - 1549.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. H. Lee, S. Lwu, J. Kim, and J. Pelletier
Inhibition of Wilms Tumor 1 Transactivation by Bone Marrow Zinc Finger 2, a Novel Transcriptional Repressor
J. Biol. Chem., November 15, 2002; 277(47): 44826 - 44837.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Baudry, M. Hamelin, M.-O. Cabanis, J.-C. Fournet, M.-F. Tournade, S. Sarnacki, C. Junien, and C. Jeanpierre
WT1 Splicing Alterations in Wilms' Tumors
Clin. Cancer Res., October 1, 2000; 6(10): 3957 - 3965.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
N. A. Little, N. D. Hastie, and R. C. Davies
Identification of WTAP, a novel Wilms' tumour 1-associating protein
Hum. Mol. Genet., September 1, 2000; 9(15): 2231 - 2239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Ladomery, J. Slight, S. Mc Ghee, and N. D. Hastie
Presence of WT1, the Wilm's Tumor Suppressor Gene Product, in Nuclear Poly(A)+ Ribonucleoprotein
J. Biol. Chem., December 17, 1999; 274(51): 36520 - 36526.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. E. Patek, M. H. Little, S. Fleming, C. Miles, J.-P. Charlieu, A. R. Clarke, K. Miyagawa, S. Christie, J. Doig, D. J. Harrison, et al.
A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome
PNAS, March 16, 1999; 96(6): 2931 - 2936.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.